It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Dysbiosis in the genital tract or gut microbiome can be associated with endometriosis. We sampled vaginal, cervical and gut microbiota from 14 women with histology proven stage 3/4 endometriosis and 14 healthy controls. The V3 and V4 regions of the 16S rRNA gene were amplified following the 16S Metagenomic Sequencing Library Preparation. Despite overall similar vaginal, cervical and intestinal microbiota composition between stage 3/4 endometriosis group and controls, we observed differences at genus level. The complete absence of Atopobium in the vaginal and cervical microbiota of the stage 3/4 endometriosis group was noteworthy. In the cervical microbiota, Gardnerella, Streptococcus, Escherichia, Shigella, and Ureoplasma, all of which contain potentially pathogenic species, were increased in stage 3/4 endometriosis. More women in the stage 3/4 endometriosis group had Shigella/Escherichia dominant stool microbiome. Further studies can clarify whether the association is causal, and whether dysbiosis leads to endometriosis or endometriosis leads to dysbiosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Koc University Faculty of Medicine, Department of Obstetrics and Gynecology, Istanbul, Turkey (GRID:grid.15876.3d) (ISNI:0000000106887552)
2 Koc University Hospital, Department of Obstetrics and Gynecology, Istanbul, Turkey (GRID:grid.15876.3d) (ISNI:0000000106887552)
3 Área de Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO-Salud Pública), Valencia, Spain (GRID:grid.15876.3d)
4 Eskisehir Osmangazi University Faculty of Medicine, Department of Pediatrics, Eskisehir, Turkey (GRID:grid.164274.2) (ISNI:0000 0004 0596 2460)
5 Área de Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO-Salud Pública), Valencia, Spain (GRID:grid.164274.2); Universitat de València, Institute for Integrative Systems Biology, Valencia, Spain (GRID:grid.5338.d) (ISNI:0000 0001 2173 938X); CIBER en Epidemiología y Salud Pública (CIBEResp), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)